miR-26a also negatively regulated ST3GAL6, a Type 2 lactosamine alpha-2,3-sialyltransferase, leading to the inhibition of Akt/mTOR signaling and reduced HCC growth both in vitro and in vivo [52]. This evidence concerns the gene ST3GAL6 and hepatocellular carcinoma.